Evidence map›Paper›PMID 40677507›Full record

ArticleCureus2025

Azathioprine Hypersensitivity Syndrome Mimicking an Infection in a Systemic Lupus Erythematosus Patient: A Case Report.

Tania Paola Lujan Chavarria, Carlos Esteban Giraldo, Natalia Andrea Uribe Ruiz, Cynthia Chavarría Muriel, Adriana Lucia Vanegas-García

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tania Paola Lujan ChavarriaInternal Medicine, San Vicente Fundacion Hospital, Medellin, COL.
Carlos Esteban GiraldoInternal Medicine, University of Antioquia, Medellin, COL.
Natalia Andrea Uribe RuizInternal Medicine, University of Antioquia, Medellin, COL.
Cynthia Chavarría MurielDentistry, Vision of the Americas University Institution, Medellin, COL.
Adriana Lucia Vanegas-GarcíaRheumatology, San Vicente Fundacion Hospital, Medellin, COL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azathioprine (AZA) is used in clinical practice as a steroid-sparing medication to treat diverse systemic autoimmune diseases, such as inflammatory bowel disease, rheumatoid arthritis, and systemic lupus erythematosus. The adverse effects of AZA use include azathioprine hypersensitivity syndrome (AHS). AHS is a rare entity, but it can lead to fatal outcomes if not identified early. Fever and abdominal pain, while resembling other diseases, can be a sign of this disease. This paper discusses the case of a patient diagnosed with systemic lupus erythematosus who experienced AHS.

Indexed as

azathioprinecase reportfeverhypersensitivity syndromesystemic lupus erythematosus

Identifiers

PMID40677507
PMCPMC12267621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.